NCT06507488 - Daphnetin Capsule In the Treatment of VaScular COgnitive Impairment Without Dementia | Biotech Hunter

Enrollment

206

Participants

Timeline

Start Date

July 7, 2025

Primary Completion Date

July 7, 2025

Study Completion Date

April 30, 2026

Conditions

Cerebrovascular Disorders

Interventions

DRUG

Daphnetin Capsule

Daphnetin, chemically known as 7,8-dihydroxycoumarin, also known as ZuShiMaJiaSu, is a class of coumarin derivatives derived from different Daphnetin genus plant .

DRUG

Placebo

The placebo is a Daphnetin Capsule simulants

Trial Locations (1)

110041

RECRUITING

Shenyang First People's Hospital, Shenyang

All Listed Sponsors

collaborator

The Fourth People's Hospital of Shenyang

UNKNOWN

lead

First People's Hospital of Shenyang

OTHER